Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Keratosis, Actinic 25Uterine Cervical Dysplasia 13Melanoma 10Carcinoma, Basal Cell 10Glioma 6Glioblastoma 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Neoplasm Metastasis 4Condylomata Acuminata 4Precancerous Conditions 3Papillomavirus Infections 3Keratosis 3Hutchinson's Melanotic Freckle 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasms 2Hemangioma, Capillary 2HIV Infections 2Ependymoma 2Colorectal Neoplasms 2Brain Neoplasms 2Astrocytoma 2Warts 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Vaginal Neoplasms 1Stomach Neoplasms 1

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 11Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5Radiotherapy 5dodecyl maltoside 4apaziquone 4tislelizumab 3Cystoscopy 3ALT-803 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 25-aminolevulinic acid hexyl ester 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1monalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Non-Muscle Invasive Bladder Neoplasms × Imiquimod × Clear all
NCT05375903 2026-01-14

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

UroGen Pharma Ltd.

Phase 1 Completed
51 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01731652 2015-02-10

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Telormedix SA

Phase 2 Completed
12 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡